145 related articles for article (PubMed ID: 3122430)
1. [Initial experiences with pro-urokinase in acute myocardial infarct].
Schanzenbächer P; Huber J; Keller F; Kochsiek K
Z Kardiol; 1987 Sep; 76(9):570-5. PubMed ID: 3122430
[TBL] [Abstract][Full Text] [Related]
2. Coronary thrombolysis with clot-selective plasminogen activators.
Collen D; Bounameaux H
Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
[TBL] [Abstract][Full Text] [Related]
3. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
4. Coronary thrombolysis in man with pro-urokinase: improved efficacy with low dose urokinase.
Kasper W; Meinertz T; Hohnloser S; Engler H; Hasler C; Rössler W; Wolf H; Welzel D; Just H; Gurewich V
Klin Wochenschr; 1988; 66 Suppl 12():109-14. PubMed ID: 3126340
[TBL] [Abstract][Full Text] [Related]
5. Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis.
de Prost D; Guerot C; Laffay N; Horellou MH; Samama M
Thromb Haemost; 1983 Dec; 50(4):792-6. PubMed ID: 6665760
[TBL] [Abstract][Full Text] [Related]
6. [Repeat thrombolysis in acute myocardial infarction].
Király C; Timár S
Orv Hetil; 2001 Apr; 142(13):665-9. PubMed ID: 11338569
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
[TBL] [Abstract][Full Text] [Related]
8. [Intracoronary thrombolytic treatment with urokinase in myocardial infarct: clinical angiographic findings and effects on left ventricular function].
Ibba GV; Terrosu P; Franceschino V; Contini G; Frau G
G Ital Cardiol; 1983 Aug; 13(8):75-84. PubMed ID: 6653959
[TBL] [Abstract][Full Text] [Related]
9. [Plasminogen activators as thrombolytic agents in myocardial infarction].
Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605
[TBL] [Abstract][Full Text] [Related]
10. Clot-selective coronary thrombolysis with pro-urokinase.
Loscalzo J; Wharton TP; Kirshenbaum JM; Levine HJ; Flaherty JT; Topol EJ; Ramaswamy K; Kosowsky BD; Salem DN; Ganz P
Circulation; 1989 Apr; 79(4):776-82. PubMed ID: 2494004
[TBL] [Abstract][Full Text] [Related]
11. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
Van de Werf F; Ludbrook PA; Bergmann SR; Tiefenbrunn AJ; Fox KA; de Geest H; Verstraete M; Collen D; Sobel BE
N Engl J Med; 1984 Mar; 310(10):609-13. PubMed ID: 6537987
[TBL] [Abstract][Full Text] [Related]
12. Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
Van de Werf F; Nobuhara M; Collen D
Ann Intern Med; 1986 Mar; 104(3):345-8. PubMed ID: 3080936
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activators and their potential in therapy.
Hollander IJ
Crit Rev Biotechnol; 1987; 6(3):253-71. PubMed ID: 3146436
[TBL] [Abstract][Full Text] [Related]
14. Coronary reperfusion studies with pro-urokinase in acute myocardial infarction: evidence for synergism of low dose urokinase.
Kasper W; Hohnloser SH; Engler H; Meinertz T; Wilkens J; Roth E; Lang K; Limbourg P; Just H
J Am Coll Cardiol; 1990 Sep; 16(3):733-8. PubMed ID: 2117622
[TBL] [Abstract][Full Text] [Related]
15. Influence of different start time of urokinase therapy after acute myocardial infarction efficacy of thrombolysis. The Collaborative Research Group on Thrombolysis.
Chin Med J (Engl); 1997 Jan; 110(1):47-9. PubMed ID: 9594321
[TBL] [Abstract][Full Text] [Related]
16. [Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct].
Bruna C; Vado A; Rossetti G; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Uslenghi E
G Ital Cardiol; 1997 Nov; 27(11):1144-52. PubMed ID: 9463058
[TBL] [Abstract][Full Text] [Related]
17. [The state of thrombolytic therapy in acute myocardial infarct].
Slany J
Wien Klin Wochenschr; 1985 Sep; 97(17):677-86. PubMed ID: 2932857
[TBL] [Abstract][Full Text] [Related]
18. [A primary report on thrombolytic therapy of acute myocardial infarction in 40 cases].
Hu D
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Jun; 19(3):143-4, 196. PubMed ID: 1914852
[TBL] [Abstract][Full Text] [Related]
19. Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis.
Flameng W; Vanhaecke J; Stump DC; Van de Werf F; Holmes W; Guenzler WA; Flohe L; Collen D
J Am Coll Cardiol; 1986 Jul; 8(1):118-24. PubMed ID: 3086416
[TBL] [Abstract][Full Text] [Related]
20. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
